» Articles » PMID: 10528050

The Effects of Parathyroidectomy on Nutritional and Biochemical Status of Hemodialysis Patients with Severe Secondary Hyperparathyroidism

Overview
Journal J Ren Nutr
Date 1999 Oct 21
PMID 10528050
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The nutritional and biochemical parameters of 15 chronic hemodialysis (HD) patients with severe secondary hyperparathyroidism who had undergone total parathyroidectomy (PTX), with a forearm implant, were retrospectively studied at 1, 3, 6, and 12 months pre- and post-PTX. The concentrations of serum calcium and phosphorous significantly decreased in the first 6 months post-PTX. The concentration of blood urea nitrogen significantly increased at 6 and 12 months post-PTX. In contrast with control chronic HD patients who had no weight gain after nonparathyroid surgery, there was a progressive weight gain leading to a significantly higher dry weight at 12 months post-PTX. There was no significant change in serum potassium, albumin, cholesterol, transferrin, bicarbonate, hematocrit, normalized protein catabolic rate (nPCR), or erythropoietin dose at any time point post-PTX. The biochemical parameters of the 8 patients who had more than 5% weight gain, during 12 months post-PTX, were not statistically different from the remaining 7 cases who had weight gain less than 5% (or had lost weight) in the same time period. The same was true for 4 patients with weight gain of more than 10% versus the latter group. In conclusion, HD patients with severe secondary hyperparathyroidism are prone to progressive weight gain post-PTX, which reaches significance by the twelfth month. In 53% of the patients, the weight gain is more than 5% above the baseline. The nutritional and biochemical parameters pre-PTX were not helpful in distinguishing those who developed significant weight gain post-PTX.

Citing Articles

Hyperparathyroidism, Serum Phosphorus and Dietary Intake in Hemodialysis Patients: Is There a Novel Relationship?.

Garagarza C, Valente A, Queiros C, Neto I, Sebastiao J, Gomes M Int J Mol Sci. 2024; 25(4).

PMID: 38396685 PMC: 10888856. DOI: 10.3390/ijms25042006.


Improvement of nutritional status after parathyroidectomy in patients receiving maintenance hemodialysis.

Disthabanchong S, Saeseow S, Khunapornphairote S, Suvikapakornkul R, Wasutit Y, Tungkeeratichai J Front Med (Lausanne). 2023; 10:1132566.

PMID: 37484844 PMC: 10359897. DOI: 10.3389/fmed.2023.1132566.


Severe hyperparathyroidism is associated with nutritional impairment in maintenance hemodialysis patients.

Disthabanchong S, Vantanasiri K, Khunapornphairote S, Chansomboon P, Buachum N, Saeseow S Front Nutr. 2022; 9:933918.

PMID: 36176632 PMC: 9513451. DOI: 10.3389/fnut.2022.933918.


Parathyroid Hormone: A Uremic Toxin.

Duque E, Elias R, Moyses R Toxins (Basel). 2020; 12(3).

PMID: 32192220 PMC: 7150960. DOI: 10.3390/toxins12030189.


Surgical and medical treatment of secondary hyperparathyroidism in patients on continuous dialysis.

Tominaga Y, Matsuoka S, Uno N World J Surg. 2009; 33(11):2335-42.

PMID: 19247704 DOI: 10.1007/s00268-009-9943-3.